| GTO ID | GTC1018 |
| Trial ID | ChiCTR2300070838 |
| Disease | Nasopharyngeal Disease |
| Altered gene | EBV |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | BRG01 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase 1 Study Evaluating the Safety and Efficacy of BRG01 in Subjects with Relapsed/Metastatic EBV-positive Nasopharyngeal Carcinoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Sun Yat-sen University Cancer Center |
| Cohort 1 | |||||||||
|
|||||||||